Top Markets
Coin of the day
PhaseRx, Inc. PhaseRx, Inc.

PhaseRx, Inc.

PZRXQ
Peringkat dalam Saham #42474
PhaseRx, Inc. is a biopharmaceutical company dedicated to developing treatments... PhaseRx, Inc. is a biopharmaceutical company dedicated to developing treatments for inherited enzyme deficiencies affecting the liver. Its therapeutic strategy involves intracellular enzyme replacement, powered by its unique Hybrid mRNA technology platform, which facilitates the production of absent enzymes directly within the body's cells. The company's pipeline includes several programs targeting urea cycle disorders, such as PRX-OTC for ornithine transcarbamylase deficiency, PRX-ASL for argininosuccinate lyase deficiency, and PRX-ASS1 for argininosuccinate synthetase deficiency. Established in 2006, PhaseRx is headquartered in Seattle, Washington.
Harga Saham
$0.0001
Terakhir disinkronkan: 2026-08-11
Kapitalisasi Pasar
$1.17K
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan PhaseRx, Inc. (PZRXQ)

Kategori

Riwayat hasil dividen untuk PhaseRx, Inc. (PZRXQ)
Hasil dividen (TTM) dari PhaseRx, Inc. (simbol saham: PZRXQ) per 2026: 0
Rata-rata hasil dividen selama 5 tahun terakhir: 0.00%
Riwayat hasil dividen untuk PhaseRx, Inc. (PZRXQ) dari 2026 hingga 2026
Hasil dividen pada akhir setiap tahun (TTM)
Tahun Hasil Dividen Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Hasil dividen (TTM) untuk perusahaan serupa atau pesaing